Type 2 diabetes can be prevented in up to 58% of people with pre-diabetes (that is, at high risk of developing type 2 diabetes).1
This short video introduces geneType™ – A comprehensive risk assessment tool that helps you and your doctor make proactive, personalised decisions about screening and prevention. Learn how geneType™ looks beyond family history to give you a clearer picture of your true cancer and disease risk.
geneType™ for Type 2 Diabetes is appropriate for:
geneType™ reports help you and your health provider translate your personal clinical, family and genetic data into an actionable preventable health plan.
Understand your baseline risk of developing type 2 diabetes.
Take risk-reducing steps that are personalised to your health.
If your question is not shown here, please Contact us directly.
Type 2 diabetes is a multifactorial disease and it is not possible to incorporate all potential risk factors into a risk prediction model.
This test is not applicable to people who have fasting glucose levels above 7.0 mmol/L. In this case, the person already has type 2 diabetes and should consult their health provider.
No.
At this time geneType™ is a self-pay test. However, your patient may use FSA/HSA to pay for the test.
*Patient eligibility dependent on personal medical history, age and sex
The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType’s™ cancer risk assessments only.
Accredited For Compliance With NPAAC Standards And ISO 15189